Wow_老虎社区_美港股上老虎

2021-06-15

Wow

IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings<blockquote>IPO预览：WalkMe、Atai Life Sciences重点推出众多产品</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":187122614,"tweetId":"187122614","gmtCreate":1623747407238,"gmtModify":1631890186152,"author":{"id":3556109639612605,"idStr":"3556109639612605","authorId":3556109639612605,"authorIdStr":"3556109639612605","name":"xhxhxh","avatar":"https://static.tigerbbs.com/eea9be18e065f350196947c8e7ee73df","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Wow</body></html>","htmlText":"<html><head></head><body>Wow</body></html>","text":"Wow","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/187122614","repostId":1175897310,"repostType":4,"repost":{"id":"1175897310","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1623725513,"share":"https://www.laohu8.com/m/news/1175897310?lang=zh_CN&edition=full","pubTime":"2021-06-15 10:51","market":"us","language":"en","title":"IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings<blockquote>IPO预览：WalkMe、Atai Life Sciences重点推出众多产品</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1175897310","media":"Benzinga","summary":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is ","content":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.<blockquote>本周的IPO阵容可能会有两位数的公司上市。以下是本周上市的一些最大、最引人注目的公司。</blockquote> AMTD Digital:Asian digital solutions platform&nbsp;AMTD Digital(NYSE:HKD)&nbsp;offers&nbsp;risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.<blockquote>尚乘数科：亚洲数字解决方案平台尚乘数科（纽约证券交易所代码：HKD）为合作伙伴提供风险解决方案和数字保险技术。该公司2020财年的收入为2160万美元，本财年前9个月的收入为1880万美元。该公司计划以6.80美元至8.20美元的价格出售1600万股ADS。</blockquote> Molecular Partners:Clinical stage biotechnology company&nbsp;Molecular Partners(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with&nbsp;Novartis(NYSE:NVS) in 2020,Amgen Inc(NASDAQ:AMGN) in 2018 and&nbsp;AbbVie Inc(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.<blockquote>分子伙伴：临床阶段生物技术公司分子伙伴（纳斯达克：MOLN）专注于在传染病、肿瘤学和眼科等领域使用其开创性的DARPin产品。公司与诺华（纽约证券交易所代码：NVS）2020年，安进公司（纳斯达克：AMGN）于2018年及艾伯维公司（纽约证券交易所股票代码：ABBV）。诺华拥有该公司6%的股份。Molecular Partners计划销售300万个广告。</blockquote> WalkMe:With a mission to change the way humans interact with technology,WalkMe(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.<blockquote>WalkMe：肩负着改变人类与技术互动方式的使命，WalkMe（纳斯达克：WKME）为组织提供解决方案。该公司有许多知名公司作为客户，包括雀巢和威立雅，这两家大型欧洲公司在文件中被列为案例研究。</blockquote> WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.<blockquote>WalkMe 2020年营收为1.48亿美元，2021年第一季度营收为4270万美元。过去12个月，该公司的收入同比增长34%。该公司有368个年收入10万美元或以上的客户，22个年收入100万美元或以上的客户。WalkMe计划以29至32美元的价格出售925万股股票。</blockquote> Convey Holding:Health care company&nbsp;Convey Holding(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.<blockquote>传达控股：保健公司康维控股（纽约证券交易所股票代码：CNVY）与美国10家最大的Medicare Advantage公司中的8家合作。2020年，该公司拥有250万Medicare Advantage会员和160万处方药计划会员。该公司2020年收入为2.829亿美元。该公司2021年第一季度收入为8260万美元。Convey Holding计划以14至16美元的价格出售1330万股股票。</blockquote> Angel Oak Mortgage:Real estate finance company&nbsp;Angel Oak Mortgage(NYSE: AOMR)&nbsp;acquiresand invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.<blockquote>天使橡树抵押贷款：房地产金融公司天使橡树抵押贷款（纽约证券交易所股票代码：AOMR）收购并投资美国的第一留置权非QM贷款和其他抵押贷款资产。截至2021年第一季度末，该公司的资产为5.349亿美元。该公司选择作为房地产投资信托基金纳税。Angel Oak Mortgage寻求以20至21美元的价格出售810万股股票。</blockquote> Lyell Immunopharma:Seeking to disrupt the T-cell reprogramming market,Lyell ImmunoPharma(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered withGlaxoSmithKline(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.<blockquote>莱尔免疫制药公司：寻求颠覆T细胞重编程市场，莱尔免疫制药公司（纳斯达克：LYEL）打算到2022年底提交四份IND。公司与葛兰素史克（纽约证券交易所股票代码：GSK）在2019年的一项交易中，在预付4500万美元后，额外的里程碑价值高达4亿美元。</blockquote> GlaxoSmithKline owns 14% of Lyell and&nbsp;Bristol-MyersSquibb(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.<blockquote>葛兰素史克拥有莱尔14%的股份和百时美施贵宝（纽约证券交易所股票代码：BMY）拥有Celgene拥有该公司5%的股份。莱尔计划以16至18美元的价格出售2500万股股票。</blockquote> Verve Therapeutics:Genetic medicine companyVerve Therapeutics(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.<blockquote>神韵疗法：基因医学公司神韵疗法（纳斯达克：VERV）专注于心血管疾病。该公司计划以16至18美元的价格出售1180万股股票。</blockquote> Atai Life Sciences:Backedby&nbsp;Palantir Technologies(NYSE:PLTR) and&nbsp;Paypal Holdings(NASDAQ:PYPL) founder Peter Thiel,Atai Life Sciences(NASDAQ:ATAI) could be one of the high profile IPOs of the week.<blockquote>阿泰生命科学：支持Palantir技术（纽约证券交易所代码：PLTR）和Paypal控股（纳斯达克：PYPL）创始人Peter Thiel，阿泰生命科学（纳斯达克：ATAI）可能是本周备受瞩目的IPO之一。</blockquote> The company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.<blockquote>该公司正在开发精神健康障碍的治疗方案。该公司拥有10个项目和6项支持技术。该公司计划以13至15美元的价格出售1,430万股股票。</blockquote> AiHui Shou International:Pre-owned consumer electronics reseller&nbsp;AiHuiShou International(NYSE: RERE)seeksto give a second life to all idle goods.<blockquote>爱辉寿国际：二手消费电子产品经销商爱回收国际（纽约证券交易所股票代码：RERE）寻求赋予所有闲置商品第二次生命。</blockquote> The company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.JD.com(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.<blockquote>该公司的三个业务线——AHS Recycle、PJUT Marketplace和PaiPai Marketplace——帮助该公司以6.6%的市场份额成为中国的市场领导者。该公司2020年营收7.415亿美元，2021年第一季度营收2.311亿美元，同比增长119%。京东（纳斯达克：JD）IPO后将拥有该公司32.3%的股份。该公司计划以13至15美元的价格出售1620万股ADS。</blockquote>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings<blockquote>IPO预览：WalkMe、Atai Life Sciences重点推出众多产品</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings<blockquote>IPO预览：WalkMe、Atai Life Sciences重点推出众多产品</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nBenzinga \n2021-06-15 10:51\n</div>\n</div>\n</h4>\n</header>\n<article>\nThis week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.<blockquote>本周的IPO阵容可能会有两位数的公司上市。以下是本周上市的一些最大、最引人注目的公司。</blockquote> AMTD Digital:Asian digital solutions platform&nbsp;AMTD Digital(NYSE:HKD)&nbsp;offers&nbsp;risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.<blockquote>尚乘数科：亚洲数字解决方案平台尚乘数科（纽约证券交易所代码：HKD）为合作伙伴提供风险解决方案和数字保险技术。该公司2020财年的收入为2160万美元，本财年前9个月的收入为1880万美元。该公司计划以6.80美元至8.20美元的价格出售1600万股ADS。</blockquote> Molecular Partners:Clinical stage biotechnology company&nbsp;Molecular Partners(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with&nbsp;Novartis(NYSE:NVS) in 2020,Amgen Inc(NASDAQ:AMGN) in 2018 and&nbsp;AbbVie Inc(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.<blockquote>分子伙伴：临床阶段生物技术公司分子伙伴（纳斯达克：MOLN）专注于在传染病、肿瘤学和眼科等领域使用其开创性的DARPin产品。公司与诺华（纽约证券交易所代码：NVS）2020年，安进公司（纳斯达克：AMGN）于2018年及艾伯维公司（纽约证券交易所股票代码：ABBV）。诺华拥有该公司6%的股份。Molecular Partners计划销售300万个广告。</blockquote> WalkMe:With a mission to change the way humans interact with technology,WalkMe(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.<blockquote>WalkMe：肩负着改变人类与技术互动方式的使命，WalkMe（纳斯达克：WKME）为组织提供解决方案。该公司有许多知名公司作为客户，包括雀巢和威立雅，这两家大型欧洲公司在文件中被列为案例研究。</blockquote> WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.<blockquote>WalkMe 2020年营收为1.48亿美元，2021年第一季度营收为4270万美元。过去12个月，该公司的收入同比增长34%。该公司有368个年收入10万美元或以上的客户，22个年收入100万美元或以上的客户。WalkMe计划以29至32美元的价格出售925万股股票。</blockquote> Convey Holding:Health care company&nbsp;Convey Holding(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.<blockquote>传达控股：保健公司康维控股（纽约证券交易所股票代码：CNVY）与美国10家最大的Medicare Advantage公司中的8家合作。2020年，该公司拥有250万Medicare Advantage会员和160万处方药计划会员。该公司2020年收入为2.829亿美元。该公司2021年第一季度收入为8260万美元。Convey Holding计划以14至16美元的价格出售1330万股股票。</blockquote> Angel Oak Mortgage:Real estate finance company&nbsp;Angel Oak Mortgage(NYSE: AOMR)&nbsp;acquiresand invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.<blockquote>天使橡树抵押贷款：房地产金融公司天使橡树抵押贷款（纽约证券交易所股票代码：AOMR）收购并投资美国的第一留置权非QM贷款和其他抵押贷款资产。截至2021年第一季度末，该公司的资产为5.349亿美元。该公司选择作为房地产投资信托基金纳税。Angel Oak Mortgage寻求以20至21美元的价格出售810万股股票。</blockquote> Lyell Immunopharma:Seeking to disrupt the T-cell reprogramming market,Lyell ImmunoPharma(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered withGlaxoSmithKline(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.<blockquote>莱尔免疫制药公司：寻求颠覆T细胞重编程市场，莱尔免疫制药公司（纳斯达克：LYEL）打算到2022年底提交四份IND。公司与葛兰素史克（纽约证券交易所股票代码：GSK）在2019年的一项交易中，在预付4500万美元后，额外的里程碑价值高达4亿美元。</blockquote> GlaxoSmithKline owns 14% of Lyell and&nbsp;Bristol-MyersSquibb(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.<blockquote>葛兰素史克拥有莱尔14%的股份和百时美施贵宝（纽约证券交易所股票代码：BMY）拥有Celgene拥有该公司5%的股份。莱尔计划以16至18美元的价格出售2500万股股票。</blockquote> Verve Therapeutics:Genetic medicine companyVerve Therapeutics(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.<blockquote>神韵疗法：基因医学公司神韵疗法（纳斯达克：VERV）专注于心血管疾病。该公司计划以16至18美元的价格出售1180万股股票。</blockquote> Atai Life Sciences:Backedby&nbsp;Palantir Technologies(NYSE:PLTR) and&nbsp;Paypal Holdings(NASDAQ:PYPL) founder Peter Thiel,Atai Life Sciences(NASDAQ:ATAI) could be one of the high profile IPOs of the week.<blockquote>阿泰生命科学：支持Palantir技术（纽约证券交易所代码：PLTR）和Paypal控股（纳斯达克：PYPL）创始人Peter Thiel，阿泰生命科学（纳斯达克：ATAI）可能是本周备受瞩目的IPO之一。</blockquote> The company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.<blockquote>该公司正在开发精神健康障碍的治疗方案。该公司拥有10个项目和6项支持技术。该公司计划以13至15美元的价格出售1,430万股股票。</blockquote> AiHui Shou International:Pre-owned consumer electronics reseller&nbsp;AiHuiShou International(NYSE: RERE)seeksto give a second life to all idle goods.<blockquote>爱辉寿国际：二手消费电子产品经销商爱回收国际（纽约证券交易所股票代码：RERE）寻求赋予所有闲置商品第二次生命。</blockquote> The company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.JD.com(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.<blockquote>该公司的三个业务线——AHS Recycle、PJUT Marketplace和PaiPai Marketplace——帮助该公司以6.6%的市场份额成为中国的市场领导者。该公司2020年营收7.415亿美元，2021年第一季度营收2.311亿美元，同比增长119%。京东（纳斯达克：JD）IPO后将拥有该公司32.3%的股份。该公司计划以13至15美元的价格出售1620万股ADS。</blockquote>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"WKME":"WalkMe Ltd.","HKD":"尚乘数科","AOMR":"ANGEL OAK MORTGAGE REIT INC","LYEL":"Lyell Immunopharma, Inc.","ATAI":"Atai Beckley Inc","MOLN":"Molecular Partners AG","RERE":"爱回收","NVS":"诺华"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175897310","content_text":"This week’s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.\nAMTD Digital:Asian digital solutions platform AMTD Digital(NYSE:HKD) offers risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.\nMolecular Partners:Clinical stage biotechnology company Molecular Partners(NASDAQ:MOLN) isfocusedon using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with Novartis(NYSE:NVS) in 2020,Amgen Inc(NASDAQ:AMGN) in 2018 and AbbVie Inc(NYSE:ABBV) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.\nWalkMe:With a mission to change the way humans interact with technology,WalkMe(NASDAQ:WKME)offerssolutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.\nWalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company’s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.\nConvey Holding:Health care company Convey Holding(NYSE:CNVY)partnerswith eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.\nAngel Oak Mortgage:Real estate finance company Angel Oak Mortgage(NYSE: AOMR) acquiresand invests in first lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.\nLyell Immunopharma:Seeking to disrupt the T-cell reprogramming market,Lyell ImmunoPharma(NASDAQ:LYEL)intendsto have four INDs submitted by the end of 2022. The company partnered withGlaxoSmithKline(NYSE:GSK) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.\nGlaxoSmithKline owns 14% of Lyell and Bristol-MyersSquibb(NYSE:BMY) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.\nVerve Therapeutics:Genetic medicine companyVerve Therapeutics(NASDAQ: VERV) isfocusedon cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.\nAtai Life Sciences:Backedby Palantir Technologies(NYSE:PLTR) and Paypal Holdings(NASDAQ:PYPL) founder Peter Thiel,Atai Life Sciences(NASDAQ:ATAI) could be one of the high profile IPOs of the week.\nThe company isdevelopingtreatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.\nAiHui Shou International:Pre-owned consumer electronics reseller AiHuiShou International(NYSE: RERE)seeksto give a second life to all idle goods.\nThe company’s three business lines — AHS Recycle, PJUT Marketplace and PaiPai Marketplace — help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year.JD.com(NASDAQ:JD) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.","news_type":1,"symbols_score_info":{"NVS":0.9,"WKME":0.9,"LYEL":0.9,"CNVY":0.9,"MOLN":0.9,"ATAI":0.9,"RERE":0.9,"HKD":0.9,"AOMR":0.9}},"isVote":1,"tweetType":1,"viewCount":2187,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/187122614"}